The DOI matches its Crossref record; the references it cites are not checked yet.
P2X Receptors in Health and Disease
Abstract
Seven P2X receptor subunits have been cloned which form functional homo- and heterotrimers. These are cation-selective channels, equally permeable to Na(+) and K(+) and with significant Ca(2+) permeability. The three-dimensional structure of the P2X receptor is described. The channel pore is formed by the α-helical transmembrane spanning region 2 of each subunit. When ATP binds to a P2X receptor, the pore opens within milliseconds, allowing the cations to flow. P2X receptors are expressed on both central and peripheral neurons, where they are involved in neuromuscular and synaptic neurotransmission and neuromodulation. They are also expressed in most types of nonneuronal cells and mediate a wide range of actions, such as contraction of smooth muscle, secretion, and immunomodulation. Changes in the expression of P2X receptors have been characterized in many pathological conditions of the cardiovascular, gastrointestinal, respiratory, and urinogenital systems and in the brain and special senses. The therapeutic potential of P2X receptor agonists and antagonists is currently being investigated in a range of disorders, including chronic neuropathic and inflammatory pain, depression, cystic fibrosis, dry eye, irritable bowel syndrome, interstitial cystitis, dysfunctional urinary bladder, and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The P2X7 receptor is widely expressed through the body [47], including in immune [48], lung [49], and CNS cells, mainly microglia and oligodendrocytes [50–52], whereas its expression in neurons and astrocytes is still under discussion [50, 51, 53–60].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [47]
Citations
The citation lists haven’t been fetched yet
References 217 · Cited by 213
Research works printed but not linked: 7
- Diez-Zaera, 2007, Purinergic system in Huntington's disease: Develop of new therapeutic strategies, Journal of Neurochemistry, 101, 66
- Fumagalli, 2006, ATP as a neurotransmitter of pain in migraine: A functional role for P2Y receptors in primary cultures from mouse trigeminal sensory ganglia, Purinergic Signalling, 2, 120
- Hegg, 2003, Inhibition of heat-shock protein induction in mouse OE by in vivo administration of purinergic receptor antagonists, Chemical Senses, 28, A110
- Lu, 2002, Voiding dysfunction and purinergic mechanisms in awake chronic spinal cord injured (SCI) rats, Society for Neuroscience
- Oses, 2006, Modification by kainate-induced convulsions of the density of presynaptic P2X receptors in the rat hippocampus, Purinergic Signalling, 2, 252
- Roberts, 2005, P2X4 purinergic receptor protein expression is upregulated in placenta from preeclamptic pregnancies, Journal of the Society of Gynecologic Investigation, 12, P363A
- Yu, 2004, Purinergic agonists sensitize pelvic afferent nerves in the vitro urinary bladder-pelvic nerve preparation of the rat, The Journal of Urology, 169, 47
Metadata
- Authors
- Burnstock, G., & Kennedy, C.
- Affiliations
- University College London (GB)
- University of Strathclyde (GB)
- Venue
- Advances in Pharmacology
- Publisher
- Elsevier
- Published
- 2011
- Volume
- 61
- Pages
- 333-372
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W1554147890
- Cited by
- 213
- References
- 217
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 18 · 2023: 13 · 2022: 16 · 2021: 16 · 2020: 14 · 2019: 12 · 2018: 8 · 2017: 18 · 2016: 9 · 2015: 13 · 2014: 12 · 2013: 17 · 2012: 16
- FWCI
- 9.77
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in pharmacology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- P2X receptors, purinergic signaling, ATP-gated ion channels, cation channels, receptor structure, heterotrimers, neuromuscular transmission, synaptic transmission, neuromodulation, smooth muscle contraction, immunomodulation, P2X receptor antagonists, pain, cystic fibrosis, dry eye, irritable bowel syndrome, interstitial cystitis, bladder dysfunction, cancer
- MeSH terms
- Animals, Disease, Health, Humans, Models, Biological, Models, Molecular, Receptors, Purinergic P2X
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review